Literature DB >> 4840445

Effects of rifamycin derivatives, alone and in combination with amphotericin B, against Histoplasma capsulatum.

G S Kobayashi, S S Cheung, D Schlessinger, G Medoff.   

Abstract

Several derivatives of rifamycin SV inhibited ribonucleic acid synthesis and decreased the viability of Histoplasma capsulatum. Both of these effects were enhanced by low concentrations of amphotericin B. The relative potency of the different rifamycin derivatives against H. capsulatum, when used in combination with amphotericin B or alone, was the same as that reported for the inhibition of the reverse transcriptase of ribonucleic acid tumor viruses.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4840445      PMCID: PMC428912          DOI: 10.1128/AAC.5.1.16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Growth of the yeastlike phase of Histoplasma capsulatum in a fluid medium.

Authors:  S B SALVIN
Journal:  J Bacteriol       Date:  1950-02       Impact factor: 3.490

2.  Inhibitors of the RNA and DNA dependent polymerase activities of RNA tumour viruses.

Authors:  C Gurgo; R K Ray; L Thiry; M Green
Journal:  Nat New Biol       Date:  1971-01-27

3.  Reverse transcriptase, RNA tumour virus transformation and derivatives of rifamycin SV.

Authors:  R C Ting; S S Yang; R C Gallo
Journal:  Nat New Biol       Date:  1972-04-12

4.  Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum.

Authors:  G S Kobbayashi; G Medoff; D Schlessinger; C N Kwan; W E Musser
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

5.  Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Authors:  G Medoff; G S Kobayashi; C N Kwan; D Schlessinger; P Venkov
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

6.  Transcription in yeast: separation and properties of multiple FNA polymerases.

Authors:  R Adman; L D Schultz; B D Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

7.  Potentiation of the antifungal effects of antibiotics by amphotericin B.

Authors:  C N Kwan; G Medoff; G S Kobayashi; D Schlessinger; H J Raskas
Journal:  Antimicrob Agents Chemother       Date:  1972-08       Impact factor: 5.191

  7 in total
  7 in total

1.  Differential potentiation by nystatin of the effect of antibiotics on yeast and mammalian cells.

Authors:  A Aszalos
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

2.  Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo.

Authors:  M Huppert; D Pappagianis; S H Sun; I Gleason-Jordan; M S Collins; K R Vukovich
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

3.  Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: demonstration of in vitro synergy between rifabutin and amphotericin B.

Authors:  C J Clancy; Y C Yu; A Lewin; M H Nguyen
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

4.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

Review 5.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

6.  In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.

Authors:  M R Moody; V M Young; M J Morris; S C Schimpff
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

7.  Sir2 histone deacetylase prevents programmed cell death caused by sustained activation of the Hog1 stress-activated protein kinase.

Authors:  Alexandre Vendrell; Mar Martínez-Pastor; Alberto González-Novo; Amparo Pascual-Ahuir; David A Sinclair; Markus Proft; Francesc Posas
Journal:  EMBO Rep       Date:  2011-09-30       Impact factor: 8.807

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.